NTUH developing promising nasal spray vaccine to combat Delta variant

A National Taiwan University Hospital (NTUH) research team announced on Tuesday that a COVID-19 nasal spray vaccine currently under development that targets the Delta variant has shown promising initial results following tests on mice.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)